MiRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease

PLoS ONE

Volumn 10, Issue 12, 2015, Pages

  Schulte, Christian ^a   Molz, Simon ^a   Appelbaum, Sebastian ^a,b   Karakas, Mahir ^a,b   Ojeda, Francisco ^a   Lau, Denise M ^a   Hartmann, Tim ^a   Lackner, Karl J ^b,c   Westermann, Dirk ^a,b   Schnabel, Renate B ^a,b   Blankenberg, Stefan ^a,b   Zeller, Tanja ^a,b  

^a UNIVERSITY HEART CENTER HAMBURG   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 126; MICRORNA 197; MICRORNA 223; UNCLASSIFIED DRUG; MIRN197 MICRORNA, HUMAN; MIRN223 MICRORNA, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RELIABILITY; RISK ASSESSMENT; STABLE ANGINA PECTORIS; BLOOD; FOLLOW UP; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PROPORTIONAL HAZARDS MODEL; RISK FACTOR;

AGED; BIOMARKERS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84956963036     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0145930     Document Type: Article

References (35)

1. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation research. 2012;110(3):483-95. Epub 2012/02/04. doi: 10.1161/CIRCRESAHA.111.247452 PMID: 22302755.
2. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circulation research. 2010;107(5):677-84. Epub 2010/07/03. doi: 10.1161/CIRCRESAHA.109.215566 PMID: 20595655.
3. Small EM, Frost RJ, Olson EN. MicroRNAs add a new dimension to cardiovascular disease. Circulation. 2010;121(8):1022-32. Epub 2010/03/03. doi: 10.1161/CIRCULATIONAHA.109.889048 PMID: 20194875; PubMed Central PMCID: PMC2847432.
4. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circulation Cardiovascular genetics. 2010;3(6):499-506. Epub 2010/10/06. doi: 10.1161/CIRCGENETICS.110.957415 PMID: 20921333.
5. Gomes da Silva AM, Silbiger VN. miRNAs as biomarkers of atrial fibrillation. Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. 2014:1-6. Epub 2014/08/30. doi: 10. 3109/1354750x.2014.954001 PMID: 25171770.
6. Engelhardt S. Small RNA biomarkers come of age. Journal of the American College of Cardiology. 2012;60(4):300-3. Epub 2012/07/21. doi: 10.1016/j.jacc.2012.04.018 PMID: 22813606.
7. Maegdefessel L. The emerging role of microRNAs in cardiovascular disease. Journal of internal medicine. 2014;276(6):633-44. Epub 2014/08/28. doi: 10.1111/joim.12298 PMID: 25160930.
8. Contu R, Latronico MV, Condorelli G. Circulating microRNAs as potential biomarkers of coronary artery disease: a promise to be fulfilled? Circulation research. 2010;107(5):573-4. Epub 2010/09/04. doi: 10. 1161/circresaha.110.227983 PMID: 20814026.
9. Bronze-da-Rocha E. MicroRNAs expression profiles in cardiovascular diseases. BioMed research international. 2014;2014:985408. Epub 2014/07/12. doi: 10.1155/2014/985408 PMID: 25013816; PubMed Central PMCID: PMCPmc4075084.
10. Jansen F, Yang X, Proebsting S, Hoelscher M, Przybilla D, Baumann K, et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. Journal of the American Heart Association. 2014;3(6):e001249. Epub 2014/10/29. doi: 10.1161/jaha.114. 001249 PMID: 25349183.
11. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. European heart journal. 2010;31(6):659-66. Epub 2010/02/18. doi: 10.1093/eurheartj/ehq013 PMID: 20159880.
12. Cheng C, Wang Q, You W, Chen M, Xia J. MiRNAs as biomarkers of myocardial infarction: a metaanalysis. PloS one. 2014;9(2):e88566. Epub 2014/02/18. doi: 10.1371/journal.pone.0088566 PMID: 24533109; PubMed Central PMCID: PMCPmc3922900.
13. Bostjancic E, Glavac D. miRNome in myocardial infarction: Future directions and perspective. World journal of cardiology. 2014;6(9):939-58. Epub 2014/10/03. doi: 10.4330/wjc.v6.i9.939 PMID: 25276296; PubMed Central PMCID: PMCPmc4176804.
14. Zeller T, Keller T, Ojeda F, Reichlin T, Twerenbold R, Tzikas S, et al. Assessment of microRNAs in patients with unstable angina pectoris. European heart journal. 2014;35(31):2106-14. Epub 2014/04/15. doi: 10.1093/eurheartj/ehu151 PMID: 24727883.
15. Schulte C, Zeller T. microRNA-based diagnostics and therapy in cardiovascular disease-Summing up the facts. Cardiovasc Diagn Ther. 2015;5(1):17-36. Epub 2015/03/17. doi: 10.3978/j.issn. 2223-3652. 2014.12.03 PMID: 25774345; PubMed Central PMCID: PMCPMC4329169.
16. Zhang Q, Kandic I, Kutryk MJ. Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. Biochemical and biophysical research communications. 2011;405(1):42-6. Epub 2011/01/05. doi: 10.1016/j.bbrc.2010.12.119 PMID: 21195052.
17. D'Alessandra Y, Carena MC, Spazzafumo L, Martinelli F, Bassetti B, Devanna P, et al. Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina. PloS one. 2013;8(11):e80345. Epub 2013/11/22. doi: 10.1371/journal.pone.0080345 PMID: 24260372; PubMed Central PMCID: PMCPmc3829878.
18. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S, Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation. 2011;124(18):1936-44. Epub 2011/10/05. doi: 10. 1161/circulationaha.111.037572 PMID: 21969012.
19. Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, et al. Human circulating microRNA-1 and micro-RNA-126 as potential novel indicators for acute myocardial infarction. International journal of biological sciences. 2012;8(6):811-8. Epub 2012/06/22. doi: 10.7150/ijbs.4439 PMID: 22719221; PubMed Central PMCID: PMCPmc3372885.
20. Li C, Fang Z, Jiang T, Zhang Q, Liu C, Zhang C, et al. Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC medical genomics. 2013;6:16. Epub 2013/05/07. doi: 10.1186/1755-8794-6-16 PMID: 23641832; PubMed Central PMCID: PMCPmc3655858.
21. Tabet F, Vickers KC, Cuesta Torres LF, Wiese CB, Shoucri BM, Lambert G, et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nature communications. 2014;5:3292. Epub 2014/03/01. doi: 10.1038/ncomms4292 PMID: 24576947; PubMed Central PMCID: PMCPMC4189962.
22. Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, et al. Circulating microRNAs as novel biomarkers for platelet activation. Circulation research. 2013;112(4):595-600. Epub 2013/01/04. doi: 10.1161/circresaha.111.300539 PMID: 23283721.
23. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation research. 2010;107(6):810-7. Epub 2010/07/24. doi: 10.1161/circresaha.110.226357 PMID: 20651284.
24. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. Journal of the American College of Cardiology. 2012;60(4):290-9. Epub 2012/07/21. doi: 10.1016/j.jacc.2012.03.056 PMID: 22813605.
25. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation. 2001;104(1):25-31. Epub 2001/07/04. PMID: 11435333.
26. Blankenberg S, Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret L, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. The New England journal of medicine. 2003;349(17):1605-13. Epub 2003/10/24. doi: 10.1056/NEJMoa030535 PMID: 14573732.
27. Wurtz P, Havulinna AS, Soininen P, Tynkkynen T, Prieto-Merino D, Tillin T, et al. Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts. Circulation. 2015;131(9):774-85. Epub 2015/01/13. doi: 10.1161/circulationaha.114.013116 PMID: 25573147; PubMed Central PMCID: PMCPMC4351161.
28. R Development Core Team (2008). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www. Rproject.org.
29. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. Journal of molecular and cellular cardiology. 2011;51(5):872-5. Epub 2011/08/03. doi: 10.1016/j.yjmcc.2011.07.011 PMID: 21806992.
30. Shan Z, Qin S, Li W, Wu W, Yang J, Chu M, et al. An Endocrine Genetic Signal Between Blood Cells and Vascular Smooth Muscle Cells: Role of MicroRNA-223 in Smooth Muscle Function and Atherogenesis. Journal of the American College of Cardiology. 2015;65(23):2526-37. Epub 2015/06/13. doi: 10. 1016/j.jacc.2015.03.570 PMID: 26065992; PubMed Central PMCID: PMCPmc4498487.
31. Johnnidis JB, Harris MH, Wheeler RT, Stehling-Sun S, Lam MH, Kirak O, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451(7182):1125-9. Epub 2008/02/19. doi: 10.1038/nature06607 PMID: 18278031.
32. Li T, Morgan MJ, Choksi S, Zhang Y, Kim YS, Liu ZG. MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nature immunology. 2010;11(9):799-805. Epub 2010/08/17. doi: 10.1038/ni.1918 PMID: 20711193; PubMed Central PMCID: PMCPmc2926307.
33. Vickers KC, Landstreet SR, Levin MG, Shoucri BM, Toth CL, Taylor RC, et al. MicroRNA-223 coordinates cholesterol homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(40):14518-23. Epub 2014/09/24. doi: 10.1073/pnas.1215767111 PMID: 25246565; PubMed Central PMCID: PMCPmc4210029.
34. Huang X, Liang M, Dittmar R, Wang L. Extracellular microRNAs in urologic malignancies: chances and challenges. International journal of molecular sciences. 2013;14(7):14785-99. Epub 2013/07/19. doi: 10.3390/ijms140714785 PMID: 23863690; PubMed Central PMCID: PMCPmc3742273.
35. Meyer SU, Kaiser S, Wagner C, Thirion C, Pfaffl MW. Profound effect of profiling platform and normalization strategy on detection of differentially expressed microRNAs-a comparative study. PloS one. 2012;7(6):e38946. Epub 2012/06/23. doi: 10.1371/journal.pone.0038946 PMID: 22723911; PubMed Central PMCID: PMCPmc3377731.